A high burden of heart valve diseases is driving its expansion. India’s transcatheter aortic valve replacement (TAVR) market ...

Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.

The global Transcatheter Aortic Valve Replacement Market is valued at $6.5 billion in 2023 and is projected to reach a value of $11.85 billion by 2032. This growth represents a compound annual growth ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

The Heart and Vascular center at Portneuf Medical Center recently marked its 400th transaortic valve replacement procedure.

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

The firm remains on the leading edge with the dominant balloon-expanded Sapien transcatheter aortic valve. It is also in a strong position to commercialize transcatheter mitral repair and ...